Sepsis: A new hypothesis for pathogenesis of the disease process

被引：659

作者：

Bone, RC ^{[1
]}

Grodzin, CJ ^{[1
]}

Balk, RA ^{[1
]}

机构：

[1] RUSH MED COLL, RUSH PRESBYTERIAN ST LUKES MED CTR, DEPT INTERNAL MED, SECT CRIT CARE MED, CHICAGO, IL 60612 USA

来源：

CHEST | 1997年 / 112卷 / 01期

关键词：

D O I：

10.1378/chest.112.1.235

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

[No abstract available]

引用

页码：235 / 243

页数：9

共 57 条

[1] EFFICACY AND SAFETY OF MONOCLONAL-ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH SEPSIS SYNDROME - A RANDOMIZED, CONTROLLED, DOUBLE-BLIND, MULTICENTER CLINICAL-TRIAL [J].

ABRAHAM, E ;

WUNDERINK, R ;

SILVERMAN, H ;

PERL, TM ;

NASRAWAY, S ;

LEVY, H ;

BONE, R ;

WENZEL, RP ;

BALK, R ;

ALLRED, R ;

PENNINGTON, JE ;

WHERRY, JC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (12) :934-941

[2] EFFECTS OF IBUPROFEN ON NEUTROPHIL FUNCTION AND ACUTE LUNG INJURY IN CANINE ENDOTOXIN-SHOCK [J].

BALK, RA ;

JACOBS, RF ;

TRYKA, AF ;

TOWNSEND, JW ;

WALLS, RC ;

BONE, RC .

CRITICAL CARE MEDICINE, 1988, 16 (11) :1121-1127

[3] THE PATHOGENESIS OF SEPSIS [J].

BONE, RC .

ANNALS OF INTERNAL MEDICINE, 1991, 115 (06) :457-469

[4] A 2ND LARGE CONTROLLED CLINICAL-STUDY OF E5, A MONOCLONAL-ANTIBODY TO ENDOTOXIN - RESULTS OF A PROSPECTIVE, MULTICENTER, RANDOMIZED, CONTROLLED TRIAL [J].

BONE, RC ;

BALK, RA ;

FEIN, AM ;

PERL, TM ;

WENZEL, RP ;

REINES, HD ;

QUENZER, RW ;

IBERTI, TJ ;

MACINTYRE, N ;

SCHEIN, RMH ;

TRENHOLME, G ;

NIEDERMAN, M ;

CHALFIN, D ;

ABALOS, A ;

OROPELLO, J ;

EMPSON, P ;

CAMINITII, S ;

GREENMAN, R ;

BOOTH, F ;

PLOUFFE, J ;

RUSSELL, J ;

GIANAKOPOULOS, G ;

IANNINI, P ;

HINDES, R ;

COBLENS, K ;

KOHLER, R ;

MARTIN, M ;

BERNARD, G ;

EDWARDS, J ;

CRISLIP, M ;

FILLER, S ;

NASRAWAY, SA ;

SIGEL, PK ;

SOTTILE, FD ;

MARTIN, DH ;

DEBOISBLANC, BP ;

CHANDRASEKAR, PH ;

BROUGHTON, WA ;

MIDDLETON, RM ;

SEIBERT, AF ;

EMMANUEL, G ;

LIE, TH ;

ANDERSON, CLV ;

PANKEY, GA ;

ANDERSON, P ;

OLSEN, K ;

SANPEDRO, GS ;

GRAHAM, D ;

GROSSMAN, J ;

WELS, PB .

CRITICAL CARE MEDICINE, 1995, 23 (06) :994-1006

[5] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].

BONE, RC ;

BALK, RA ;

CERRA, FB ;

DELLINGER, RP ;

FEIN, AM ;

KNAUS, WA ;

SCHEIN, RMH ;

SIBBALD, WJ ;

ABRAMS, JH ;

BERNARD, GR ;

BIONDI, JW ;

CALVIN, JE ;

DEMLING, R ;

FAHEY, PJ ;

FISHER, CJ ;

FRANKLIN, C ;

GORELICK, KJ ;

KELLEY, MA ;

MAKI, DG ;

MARSHALL, JC ;

MERRILL, WW ;

PRIBBLE, JP ;

RACKOW, EC ;

RODELL, TC ;

SHEAGREN, JN ;

SILVER, M ;

SPRUNG, CL ;

STRAUBE, RC ;

TOBIN, MJ ;

TRENHOLME, GM ;

WAGNER, DP ;

WEBB, CD ;

WHERRY, JC ;

WIEDEMANN, HP ;

WORTEL, CH .

CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874

[6] Why sepsis trials fail [J].

Bone, RC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (07) :565-566

[7] Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: What we do and do not know about cytokine regulation [J].

Bone, RC .

CRITICAL CARE MEDICINE, 1996, 24 (01) :163-172

[8] Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS) [J].

Bone, RC .

ANNALS OF INTERNAL MEDICINE, 1996, 125 (08) :680-687

[9]

BROWDER W, 1990, ANN SURG, V211, P605

[10]

CHEADLE WG, 1989, IMMUNE CONSEQUENCES, P119

← 1 2 3 4 5 6 →